Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

Completed · Phase 3

Conditions studied: Low Back Pain, Migraine, Diabetic Neuropathies, Osteoarthritis

In brief

The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl for the potential treatment of breakthrough pain episodes in patients who have chronic noncancer pain.

Key facts

Study ID
NCT00228605
Run by
Cephalon
People needed
500
Starts
2005-03-01
Expected to finish
2007-05-01
Last updated by the study team
2014-05-09

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.